JG
BDSI

Joel Greenblatt’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Joel Greenblatt’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-21,654
Closed -$81K – 1144
2020
Q3 		$81K Sell
21,654
-68,028
-76% -$290K ﹤0.01% 988
2020
Q2 		$391K Buy
+89,682
New +$403K 0.01% 807

Other funds holding BDSI

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Joel Greenblatt's BDSI Position: Q4 2020 in Review

Joel Greenblatt sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2020, closing a stake of 21,654 shares — an estimated $81K sold.

Joel Greenblatt first reported a position in BDSI in Q2 2020 and held it in 2 quarters. The position peaked at $391K in Q2 2020. 145 funds tracked by Wall St. Rank hold BDSI as of Q4 2020.

  • Joel Greenblatt reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2020 after selling out during the quarter.
  • Joel Greenblatt sold 21,654 BioDelivery Sciences International, Inc. shares in Q4 2020, an estimated $81K.
  • Joel Greenblatt first reported a position in BioDelivery Sciences International, Inc. in Q2 2020 and held it in 2 quarters.
  • Joel Greenblatt's BioDelivery Sciences International, Inc. position peaked at $391K in Q2 2020.
  • 145 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2020.

Based on Gotham Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.